Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Xtant Medical Holdings (XTNT) Change in Inventory (2016 - 2025)

Xtant Medical Holdings has reported Change in Inventory over the past 16 years, most recently at $1.4 million for Q3 2025.

Quarterly Change in Inventory fell 5.7% to $1.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$374000.0 through Sep 2025, down 106.37% year-over-year, with the annual reading at $2.5 million for FY2024, 32.24% up from the prior year.
Change in Inventory was $1.4 million for Q3 2025 at Xtant Medical Holdings, up from $814000.0 in the prior quarter.
Over five years, Change in Inventory peaked at $2.2 million in Q1 2024 and troughed at -$3.2 million in Q4 2024.
The 5-year median for Change in Inventory is $383000.0 (2021), against an average of $299842.1.
The largest YoY upside for Change in Inventory was 2485.94% in 2024 against a maximum downside of 1557.6% in 2024.
A 5-year view of Change in Inventory shows it stood at -$1.5 million in 2021, then surged by 135.83% to $536000.0 in 2022, then crashed by 59.51% to $217000.0 in 2023, then crashed by 1557.6% to -$3.2 million in 2024, then surged by 145.53% to $1.4 million in 2025.
Per Business Quant, the three most recent readings for XTNT's Change in Inventory are $1.4 million (Q3 2025), $814000.0 (Q2 2025), and $535000.0 (Q1 2025).